Attorneys general from New York, California, Massachusetts, and New Jersey have petitioned the Food and Drug Administration (FDA) to remove existing restrictions on the abortion pill mifepristone.
FDA Commissioner Marty Makary confirmed that he will review the safety of the abortion drug mifepristone after a study revealed troubling adverse health outcomes exceeding the risks reported on its label.
The Department of Health and Human Services (HHS) has directed health care providers and state boards to update treatment guidelines to reflect the Trump administration's review of minors with gender dysphoria.
Health officials for the United States and Argentina released a joint statement urging countries to leave the World Health Organization (WHO) and form a new entity rooted in "scientific integrity, transparency, and the defense of human dignity."
The U.S. Centers for Disease Control and Prevention (CDC) pulled its recommendation that healthy children and pregnant women receive the COVID-19 vaccine.